The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.
Tema Oncology ETF · Issued by Tema
| RVMD | Revolution Medicines Inc Ordinary Shares | 6.07% |
| LLY | Eli Lilly and Co | 5.20% |
| COGT | Cogent Biosciences Inc | 4.74% |
| RHHBY | Roche Holding AG ADR | 4.21% |
| NOVN.SW | Novartis AG Registered Shares | 3.82% |
| BMY | Bristol-Myers Squibb Co | 3.60% |
| MRK | Merck & Co Inc | 3.59% |
| ABBV | AbbVie Inc | 3.35% |
| HALO | Halozyme Therapeutics Inc | 3.21% |
| ONC | BeOne Medicines Ltd ADR | 3.21% |
No recent news for CANC. The ingest cron pulls every 15 minutes during market hours.